Jonathan Harry Ross, MD
Jonathan Ross, MD, is Chief of the Division of Pediatric Urology at University Hospitals Rainbow Babies & Children's Hospital. He also operates at UH Ahuja Medical Center and UH Westlake Health Center and sees patients at UH Parma Medical Center and UH University Suburban and UH Medina health centers. He is Professor, Urology, and Assistant Professor, Pediatrics, Case Western Reserve University School of Medicine.
Dr. Ross is board certified in urology and pediatric urology. His special interests include urinary tract and genital abnormalities in children, kidney, bladder and testicle tumors in children and minimally invasive surgery.
Dr. Ross earned a bachelor’s degree in biology from Amherst College, Amherst, Mass., where he was inducted to Phi Beta Kappa and selected for the Frank Fowler Dow Prize and the John Woodruff Simpson Scholarship for Graduate Studies. He completed his doctorate in medicine at the University of Michigan Medical School, Ann Arbor, Mich., where he was elected to Alpha Omega Alpha Medical Honor Society and graduated with honors in academics and research. He served his residency in urology at Cleveland Clinic, Cleveland, Ohio, and a fellowship in pediatric urology at Children's Hospital of Michigan, Detroit, Mich.
Dr. Ross joined the UH Rainbow Babies & Children's Hospital staff in 2009. Prior to that he was Chief of Pediatric Urology at Cleveland Clinic, the position he had held since 1998.
His research interest is in pediatric urological oncology, including childhood tumors of the kidney (Wilm’s tumor), bladder and testicles. A nationally recognized expert in pediatric urology and urologic oncology, Dr. Ross has published more than 60 research papers and editorials in peer-reviewed medical journals and authored or co-authored more than 40 textbook chapters on his specialty.
He is a reviewer for leading publications in the field, including Journal of Urology, Urology and Journal of Pediatric Urology. He also has been a frequent guest speaker and lecturer at national and regional meetings, speaking on the latest treatments for difficult clinical problems in pediatric urology.
Dr. Ross is President of the Pediatric Urologic Oncology Working Group of the Society for Pediatric Urology and a member of the American Association of Pediatric Urologists and the Children’s Oncology Group.
Honors and Recognition
Phi Beta Kappa
Frank Fowler Dow Prize, 1982
John Woodruff Simpson Scholarship for Graduate Studies, 1982
University of Michigan Medical School
Medical Student Research Grant, 1982
Longway Scholarship, 1982
Alpha Omega Alpha Medical Honor Society
Hewlett Packard Top Medical Graduate Award, 1986
Pediatric urological oncology, including childhood tumors of the kidney (Wilm’s tumor), bladder and testicles
- Blood in the Urine
- Congenital and Acquired Abnormalities of the Urinary Tract and Genitalia in Children
- Kidney Stones
- Minimally Invasive Surgery
- Pain With Urination
- Pediatric Tumors of Kidney, Bladder and Testicles
- Pediatric Urology
- Robotic-Assisted Surgery
- Undescended Testicles
- Urinary Tract Infections
UH Rainbow Babies and Children's Hospital
11100 Euclid Ave
Cleveland OH, 44106
Patient Satisfaction Reviews
0 out of 5
- Pediatric Urology - American Board of Urology
- Urology - American Board of Urology
Fellowship | Pediatric Urology
Pediatric Urology - Children's Hospital Of Michigan (1991 - 1992)
Residency | Urology
Urology - Cleveland Clinic (1986 - 1991)
University Of Michigan Medical School (1986)
Amherst College (1982)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Jonathan Harry Ross did not disclose any Outside Relationships with Industry.